Brain Stimulation for Epilepsy
Overview
Authors
Affiliations
Brain stimulation has been receiving increasing attention as an alternative therapy for epilepsy that cannot be treated by either antiepileptic medication or surgical resection of the epileptogenic focus. The stimulation methods include transcranial magnetic stimulation (TMS) or electrical stimulation by implanted devices of the vagus nerve (VNS), deep brain structures (DBS) (thalamic or hippocampal), cerebellar or cortical areas. TMS is the simplest and least invasive approach. However, the most common epileptogenic areas (mesial temporal structures) probably lie too deep beneath the surface of the skull for effective TMS. The efficacy of VNS in reducing the frequency or severity of seizures is quite variable and depends on many factors which are currently investigated. VNS is well-tolerated and approved in many countries. DBS is much more invasive than either TMS or VNS. Currently, a number of targets for DBS are investigated including caudate, centromedian or anterior thalamic nuclei, and subthalamic nucleus. Direct stimulation of the epileptic cortical focus is another approach to the neuromodulation in epilepsy. Finally, another line of research investigates the usefulness of implantable seizure detection devices. The current chapter presents the most important evidence on the above methods. Furthermore, other important issues are reviewed such as the selection criteria of patients for brain stimulation and the potential role of brain stimulation in the treatment of depression in epileptic patients.
Effects of central nervous system electrical stimulation on non-neuronal cells.
Williams N, Kushwah N, Dhawan V, Zheng X, Cui X Front Neurosci. 2022; 16:967491.
PMID: 36188481 PMC: 9521315. DOI: 10.3389/fnins.2022.967491.
Beynon A, Luijten B, Mylanus E Audiol Res. 2021; 11(4):691-705.
PMID: 34940020 PMC: 8698912. DOI: 10.3390/audiolres11040062.
Hao J, Luo W, Xie Y, Feng Y, Sun W, Peng W Front Hum Neurosci. 2021; 15:637071.
PMID: 33815082 PMC: 8009991. DOI: 10.3389/fnhum.2021.637071.
Fregni F, El-Hagrassy M, Pacheco-Barrios K, Carvalho S, Leite J, Simis M Int J Neuropsychopharmacol. 2020; 24(4):256-313.
PMID: 32710772 PMC: 8059493. DOI: 10.1093/ijnp/pyaa051.
Giovanni A, Capone F, di Biase L, Ferreri F, Florio L, Guerra A Front Aging Neurosci. 2017; 9:189.
PMID: 28659788 PMC: 5468377. DOI: 10.3389/fnagi.2017.00189.